Skip to main content
. 2018 Mar 19;41(6):3537–3550. doi: 10.3892/ijmm.2018.3575

Figure 4.

Figure 4

Validation of selected DElncRNAs and DEmRNAs in GSE56815. The x-axes show PMOP (case) and normal control groups, and the y-axes show the log2 transformation to the intensities. Student's t-test was used to calculate the significant differences in DElncRNAs and DEmRNAs between PMOP and normal control groups. (A) alkaline phosphatase, liver/bone/kidney; (B) suppressor of cytokine signaling 3; (C) CD177; (D) secretory leukocyte peptidase inhibitor; (E) LINC00963. DE, differentially expressed; lncRNAs, long non-coding RNAs; PMOP, post-menopausal osteoporosis.